Pharmacopeia, Inc. (ACCL) (Prev: PCOP) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacopeia, Inc. (ACCL) (Prev: PCOP)

ACCL 4.028

+0.7%

Nov 6 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Lang who wrote ()	5/8/1997 10:36:00 AM
From: tommysdad	of 179

Jim Yours is a good post and a thread on Pharmacopeia is overdue. I would add the following correction, though: all combinatorial chemistry companies claim to "more rapidly synthesize" libraries than their compeitors can. PCOP's technology is very good, but not necessarily the "best" nor the "fastest". PCOP's major scientific selling point, to my mind, is their ability to deliver what they promise and their quality control. A major problem with some libraries from other companies is the compounds in the vials are not what the labels say they are -- I've never heard anyone complain about a PCOP library. In addition, they are not just making "me too" libraries-- they are making novel libraries (important for patent issues and finding really novel leads). From an investor's point of view, their business model is very attractive and they have top-flight people running the company. I look forward to following the comments of others about this company.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next